You are here

  • Home
  • Online First
  • Endovascular therapy might be a treatment option for mild stroke due to proximal occlusions but not M2 occlusions

Article Text

Article menu
Download PDFPDF
Letter
Endovascular therapy might be a treatment option for mild stroke due to proximal occlusions but not M2 occlusions
  1. Chun-Hsien Lin1,
  2. Jeffrey L Saver2,3,
  3. Meng Lee1
  1. 1Neurology, Chang Gung Memorial Hospital Chiayi Branch, Puzi, Taiwan
  2. 2Neurology, UCLA, Los Angeles, California, USA
  3. 3Comprehensive Stroke Center and Neurology, David Geffen School of Medicine, Los Angeles, California, USA
  1. Correspondence to Dr Meng Lee, Neurology, Chang Gung Memorial Hospital, Chiayi Branch 6 West Section, Chiapu Road, Puzi 613, Taiwan; menglee5126{at}gmail.com

http://dx.doi.org/10.1136/neurintsurg-2022-019098

Statistics from Altmetric.com

    We appreciate the letter from Zheng et al1 suggesting that the random effects model, not the fixed effects model, should be used to pool the results for our meta-analysis.2 In a sensitivity test, pooled results from the random effects model did not significantly show that endovascular therapy (EVT) compared with best medical management was associated with a higher rate of being disability free for patients with acute ischemic stroke (AIS) with National Institutes of Health Stroke Scale (NIHSS) scores of ≤5 due to proximal internal carotid artery (ICA) or …

    View Full Text

    Footnotes

    • Contributors All authors contributed equally.

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial, or not-for-profit sectors.

    • Competing interests None declared.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Copyright information:

    © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.

    Linked Articles